Clinical Trial Update: Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-071) [Phase 3]

View source ↗

Summary

This entry describes a completed Phase 3 trial evaluating a marketed drug for menstrual migraine. The sponsor is Organon and Co.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Snippet

Sponsor: Organon and Co | Conditions: Migraine | Phase 3 | Status: COMPLETED